期刊文献+

非酒精性脂肪性肝病的非药物治疗进展 被引量:2

Progress in Non-drug Treatment of Non-alcoholic Fatty Liver Disease
下载PDF
导出
摘要 非酒精性脂肪性肝病(NAFLD)为国内外最常见的肝病之一,其发病率逐渐上升,但药物治疗的疗效并不确切,近年NAFLD的非药物治疗逐渐受到重视.生活方式改变和减肥手术均可对NAFLD产生积极影响,红外肝病治疗仪亦能起一定作用.尽管NAFLD的治疗手段逐渐多样化,但目前尚缺乏更多的随机对照试验来证实其有效性. Non-alcoholic fatty liver disease (NAFLD) is one of the most commonly seen liver disorders, and the prevalence is becoming higher and higher both at home and abroad. Considering the effect of pharmacotherapy is uncertain, more and more emphasis has been paid on non-drug treatment of NAFLD recently. Improving lifestyle and bariatric surgery are beneficial to NAFLD and the infra-red therapeutic instrument for hepatic diseases may also play some roles in the treatment of NAFLD. Nowadays there are various methods for the treatment of NAFLD, however, randomized controlled trials are needed to identify the efficacy.
出处 《胃肠病学》 2010年第3期169-171,共3页 Chinese Journal of Gastroenterology
关键词 非酒精性脂肪性肝病 生活方式 减肥手术 物理治疗 Non-Alcoholic Fatty Liver Disease Life Style Bariatric Surgery Physical Therapy
  • 相关文献

参考文献24

  • 1Fatty Liver and Alcoholic Liver Disease Study Group of the Chinese Liver Disease Association..非酒精性脂肪性肝病诊疗指南[J].中华肝脏病杂志,2006,14(3):161-163. 被引量:1512
  • 2Fan JG, Farrell GC. Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol, 2009, 50 (1): 204-210. 被引量:1
  • 3Aithal GP, Thomas JA, Kaye PV, et al. Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis. Gastroenterology, 2008, 135 (4): 1176-1184. 被引量:1
  • 4Ratziu V, Giral P, Jacqueminet S, et al; LIDO Study Group. Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial. Gastroenterology, 2008, 135 (1): 100-110. 被引量:1
  • 5Leite NC, Salles GF, Araujo AL, et al. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int, 2009, 29 (1): 113-119. 被引量:1
  • 6Bellentani S, Dalle Grave R, Suppini A, et al; Fatty Liver Italian Network. Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approach. Hepatology, 2008, 47 (2): 746-754. 被引量:1
  • 7de Luis DA, Aller hypocaloric diet in R, Izaola O, et al. Effect of a in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance. Diabetes Res Clin Pract, 2008, 79 (1): 74-78. 被引量:1
  • 8Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, et al. Long term nutritional intake and the risk for nonalcoholic fatty liver disease (NAFLD): a population based study. J Hepatol, 2007, 47 (5): 711-717. 被引量:1
  • 9Tendler D, Lin S, Yancy WS Jr, et al. The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci, 2007, 52 (2): 589-593. 被引量:1
  • 10Zivkovic AM, German JB, Sanyal AJ. Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease. Am J Clin Nutr, 2007, 86 (2): 285-300. 被引量:1

二级参考文献34

共引文献1515

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部